by Steven Grossman | Jul 25, 2025 | Uncategorized
Dear FDA Matters subscribers–—Each “Q&A Friday” will go to subscribers first, then posted on the website a week later. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon receipt.Subscribers are encouraged...
by Steven Grossman | Jul 19, 2025 | Uncategorized
Dear FDA Matters subscribers–—Second edition of Q&A Friday, a new feature for subscribers. Each “Q&A Friday” will go to subscribers first, then posted on the website a week later. It is on the record, so subscribers (including reporters) can use and circulate...
by Steven Grossman | Jul 18, 2025 | Short Takes and Updates
A little under half of the FDA’s roughly $7 billion budget is funded by user fees. Tobacco user fees pay for the entire tobacco program, while medical product user fees pay for between 20% and 70% of most medical programs.Food programs are, effectively, “all taxpayer...
by Steven Grossman | Jul 8, 2025 | Short Takes and Updates
“The One Big Beautiful Bill Act” (aka OBBBA) was signed into law on July 4, 2025. The immediate and long-term consequences of this bill are the most important story to write about today. Other topics can wait. ———————Whether...
by Steven Grossman | Jul 4, 2025 | Uncategorized
Dear FDA Matters subscribers–Introducing Q&A Friday, a new feature for subscribers.Each Friday’s Q&A will go to subscribers first, then it will be posted on the website about a week later. Like all FDA Matters analysis (including everything on the website) it...
